Blood proteins may signal MS years before diagnosis
Key Takeaway
Some blood proteins were linked to MS risk before diagnosis, but the study did not establish a test for predicting MS.
What They Found
Researchers found 39 blood proteins linked to MS risk using genetic and blood protein data. Most were connected to immune activity. In blood samples collected before diagnosis, 8 of 28 measured proteins were linked to when MS was diagnosed. One protein showed a consistent link with lower MS risk and less severe disease. The findings may help researchers develop an early blood test, but this study did not establish one.
Who Should Care and Why
The study included people with MS and people without MS. Some participants gave blood samples before they were diagnosed with MS. Those samples let researchers look for changes that appeared before diagnosis. The findings concern MS risk and severity, not a specific form of MS. They may matter to people interested in how MS begins, though no ready-to-use test was established.
Important Considerations
You should know that the blood-sample comparison included 124 people later diagnosed with MS and 52,515 people who were not. This was an analysis of existing genetic and blood data, not a trial of a treatment. You cannot use these findings to tell whether an individual person will develop MS.
AI-generated summary — for informational purposes only, not medical advice
Categories:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/16/2026
Two rare conditions can look like MS. An Italian study links certain treatments to more time without
Read More
10/15/2026
Researchers suggest adding a drug after stem cell transplant to help keep MS from returning. Learn h
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.